Results 1 to 10 of about 208,254 (303)

Systemic immunoglobulin light chain amyloidosis [PDF]

open access: yesNature Reviews Disease Primers, 2018
Systemic immunoglobulin light chain amyloidosis is a protein misfolding disease caused by the conversion of immunoglobulin light chains from their soluble functional states into highly organized amyloid fibrillar aggregates that lead to organ dysfunction.
Merlini G.   +6 more
exaly   +10 more sources

Germline polymorphisms and alternative splicing of human immunoglobulin light chain genes [PDF]

open access: yesiScience, 2021
Summary: Inference of germline polymorphisms in immunoglobulin genes from B cell receptor repertoires is complicated by somatic hypermutations, sequencing/PCR errors, and by varying length of reference alleles.
Ivana Mikocziova   +5 more
doaj   +2 more sources

Hereditary systemic immunoglobulin light-chain amyloidosis [PDF]

open access: yesBlood, 2015
Several members of a family died from renal failure as a result of systemic amyloidosis. Extensive studies to detect previously documented gene mutations associated with amyloidosis failed to identify a causative factor.
Benson, Merrill D.   +2 more
core   +4 more sources

Localized Immunoglobulin Light-Chain Amyloidosis of the Ulnar Nerve [PDF]

open access: yesCase Reports in Neurology, 2021
Amyloidosis is a disorder caused by extracellular tissue deposition of insoluble fibrils. Amyloidosis can be divided into systemic or localized disease. Primary systemic amyloidosis is a multisystem disease caused by the deposition of amyloid in various ...
Shinsuke Morisaki   +5 more
doaj   +2 more sources

Clinical characteristics and prognosis of immunoglobulin light chain amyloidosis patients [PDF]

open access: yesFrontiers in Medicine
ObjectiveTo analyze the prognostic factors associated with overall survival (OS) in patients diagnosed with immunoglobulin light chain (AL) amyloidosis, with the goal of improving risk stratification and patient management.MethodsA retrospective cohort ...
Lijun Song   +9 more
doaj   +2 more sources

Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021 [PDF]

open access: yesBlood Cancer Journal, 2021
Immunoglobulin light chain amyloidosis (AL) commonly presents with nephrotic range proteinuria, heart failure with preserved ejection fraction, nondiabetic peripheral neuropathy, unexplained hepatomegaly or diarrhea, and should be considered in patients ...
M. Hasib Sidiqi, Morie A. Gertz
doaj   +2 more sources

Restrictive Atrial Dysfunction in Cardiac Amyloidosis: Differences between Immunoglobulin Light Chain and Transthyretin Cardiac Amyloidosis Patients [PDF]

open access: yesBiomedicines, 2022
Background: In cardiac amyloidosis, the prevalence of thromboembolic events and atrial fibrillation is higher in transthyretin amyloidosis compared to immunoglobulin light chain amyloidosis.
Mathijs O. Versteylen   +3 more
doaj   +2 more sources

Modeling immunoglobulin light chain amyloidosis in Caenorhabditis elegans [PDF]

open access: yesDisease Models & Mechanisms
Margherita Romeo   +12 more
doaj   +2 more sources

Immunoglobulin light chain amyloidosis [PDF]

open access: yesmemo - Magazine of European Medical Oncology, 2021
SummaryImmunoglobulin light chain (AL) amyloidosis is a rare and underdiagnosed life-threatening systemic disease, primarily caused by insoluble depositions of misfolded monoclonal light chains. The monoclonal light chain paraprotein originates from a small clonal B‑cell or a clonal plasma cell population.
Hermine Agis, Maria T. Krauth
openaire   +1 more source

IgM-Related Immunoglobulin Light Chain (AL) Amyloidosis

open access: yesHemato, 2022
Waldenström macroglobulinemia (WM) is a rare lymphoplasmacytic disorder characterized by an IgM paraprotein. The clinical presentation of WM varies and can include common manifestations such as anemia and hyperviscosity, in addition to less common ...
Shayna Sarosiek   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy